Cost-of-Illness and the Health-Related Quality of Life of Patients in the Dengue Fever Outbreak in Hanoi in 2017

Bach Xuan Tran, Giang Thu Vu, Long Hoang Nguyen, Anh Tuan Le Nguyen, Tung Thanh Tran, Binh Thanh Nguyen, Thao Phuong Thi Thai, Carl A. Latkin, Cyrus S. H. Ho and Roger C. M. Ho
Additional contact information
Bach Xuan Tran: Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi 100000, Vietnam
Giang Thu Vu: Institute for Global Health Innovations, Duy Tan University, Da Nang 550000, Vietnam
Long Hoang Nguyen: School of Medicine and Pharmacy, Vietnam National University, Hanoi 100000, Vietnam
Anh Tuan Le Nguyen: Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi 100000, Vietnam
Tung Thanh Tran: Institute for Global Health Innovations, Duy Tan University, Da Nang 550000, Vietnam
Binh Thanh Nguyen: Institute for Global Health Innovations, Duy Tan University, Da Nang 550000, Vietnam
Thao Phuong Thi Thai: Department of General Planning and Department of Cardiology, Friendship Hospital, Hanoi 100000, Vietnam
Carl A. Latkin: Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
Cyrus S. H. Ho: Department of Psychological Medicine, National University Hospital, Singapore 119074, Singapore
Roger C. M. Ho: Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore

IJERPH, 2018, vol. 15, issue 6, 1-9

Abstract: Dengue fever (DF) outbreaks occur intermittently in Vietnam, and the most recent epidemic happened in 2017. However, attempts to measure the burden of DF in relation to the quality of life and the cost of treatment for patients during an epidemic period are constrained. This study explored the health-related quality of life (HRQOL) and the cost of illness among patients with dengue fever in Vietnam. A cross-sectional study was conducted in Bach Mai Hospital from September to November 2017. The EuroQol-5 dimensions-5 levels (EQ-5D-5L) was used to measure HRQOL. Cost-of illness was measured by collecting data about the direct medical cost, the non-medical cost, and the indirect cost. Among 225 patients, most of the participants experienced problems regarding mobility (62.3%), self-care (71.8%), usual activities (64.6%), and anxiety/depression (64.1%). The mean EQ-5D index was 0.66 (SD = 0.24). The median cost of illness for inpatient and outpatient groups were US $110.10 (IQR = US $4.40–1200.00) and US $36.10 (IQR = US $1.80–816.30), respectively. Indirect costs accounted for a major proportion in both groups. Lower-skilled workers and those with a higher severity of the disease had significantly lower HRQOL. Meanwhile, people who were inpatients, had comorbidities, had higher incomes, and who experienced a longer disease duration, had a higher cost of treatment. In conclusion, high costs and severe health deterioration, especially in psychological dimensions, were found in patients with DF in Vietnam. Strengthening primary health care services and communication campaigns are necessary to relieve the burden of diseases and could possibly contribute to effective DF control and prevention strategies.

Keywords: dengue fever; quality of life; cost of illness; Vietnam (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/15/6/1174/pdf (application/pdf)
https://www.mdpi.com/1660-4601/15/6/1174/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:15:y:2018:i:6:p:1174-:d:150671

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().